CONMED Corp (CNMD): debt financing — CONMED secures $450M incremental term loan facility to repurchase convertible notes due 2026

CONMED Corp

Aggregate $450M in incremental delayed draw term A-2 loans available for single draw on or before June 14, 2026.
Proceeds to repurchase a portion of CONMED's outstanding 2.25% Convertible Senior Notes due 2026 and pay fees.
Term A-2 Facility matures June 10, 2030; interest rate SOFR + 1.125%-2.25% (initial 1.75% for SOFR).
Amends existing Credit Agreement and Guarantee and Collateral Agreement; lenders include JPMorgan, PNC, Goldman Sachs, BofA, Wells Fargo, DNB, Capital One, Hancock Whitney.
Facility is secured by same assets and guaranteed by same subsidiaries as existing credit obligations.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

CONMED Corp incurred credit facility of $450 million with JPMorgan Chase Bank, N.A., as administrative agent at Adjusted term SOFR plus margin ranging from 1.125% to 2.25% per annum; base rate maturing June 10, 2030.

Instrument: credit facility
Principal: $450 million
Counterparty: JPMorgan Chase Bank, N.A., as administrative agent
Rate: Adjusted term SOFR plus margin ranging from 1.125% to 2.25% per annum; base rate
Maturity: June 10, 2030
Event: incurrence

Exact text from the filing

CONMED entered into the First Amendment to, among other things, obtain commitments for incremental senior secured delayed draw term “a” loans available in U.S. dollars to CONMED in an aggregate principal amount equal to $450 million (the “ Term A-2 Loan Facility ”), which is available to be borrowed in a single drawing on or prior to June 14, 2026.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

CONMED Corp amended First Omnibus Amendment and Increased Facility Activation Notice with the several banks and other financial institutions party thereto, as lenders; and JPMorgan Chase Bank, N.A., as administrative agent valued at $450 million (effective 2026-05-27).

Action: amendment
Agreement: credit facility
Counterparty: the several banks and other financial institutions party thereto, as lenders; and JPMorgan Chase Bank, N.A., as administrative agent
Value: $450 million
Effective: 2026-05-27

Exact text from the filing

On May 27, 2026, CONMED Corporation, a Delaware corporation (“ CONMED ”) entered into the First Omnibus Amendment and Increased Facility Activation Notice (the “ First Amendment ”), among CONMED and its subsidiary Linvatec Nederland B.V., a Netherlands private limited company ( besloten vennootschap ), as borrowers; certain of CONMED’s other subsidiaries, as guarantors; the several banks and other financial institutions party thereto, as lenders; and JPMorgan Chase Bank, N.A., as administrative agent (the “ Administrative Agent ”).

View on SEC.gov

Browse all debt financings →

CONMED Corp filing history →

Source: SEC EDGAR

accession 0002077096-26-000190

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.